Acumen Pharmaceuticals (ABOS) Capital Expenditures (2021 - 2025)
Acumen Pharmaceuticals (ABOS) posted Capital Expenditures of $9000.0 for Q2 2025, down 88.61% sequentially from $79000.0 in Q1 2025, and up 80.0% YoY from $5000.0 in Q2 2024.
Acumen Pharmaceuticals (ABOS) Capital Expenditures (2021 - 2025) Analysis & Trends
Acumen Pharmaceuticals has reported Capital Expenditures for 5 years, with the latest figure at $9000.0 in Q2 2025.
- Quarterly Capital Expenditures rose 80.0% year-over-year to $9000.0 in Q2 2025, while the trailing twelve-month figure through Mar 2026 was $9000.0 (down 89.29% YoY) and the FY2025 annual result came in at $88000.0, up 450.0% from the prior year.
- Capital Expenditures slipped to $9000.0 in Q2 2025 per ABOS's latest filing, from $79000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $84000.0 in Q3 2022 and troughed at $5000.0 in Q2 2024.
- A 5-year average of $26666.7 and a median of $12500.0 in 2023 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2022 and 2023: Capital Expenditures soared 950.0% in 2022, then tumbled 91.67% in 2023.
- Over 5 years, Capital Expenditures stood at $26000.0 in 2021, then jumped by 34.62% to $35000.0 in 2022, then slumped by 60.0% to $14000.0 in 2023, then sank by 64.29% to $5000.0 in 2024, then soared by 80.0% to $9000.0 in 2025.
- According to Business Quant data, Capital Expenditures over the past three periods registered $9000.0, $79000.0, and $5000.0 for Q2 2025, Q1 2025, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 251.02 Mn |
| 10 | Acumen Pharmaceuticals | 226.87 Mn | 226.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 9,000.00 |
| Jun 30, 2025 | 9,000.00 |
| Mar 31, 2025 | 79,000.00 |
| Mar 31, 2025 | 79,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Dec 31, 2023 | 14,000.00 |
| Dec 31, 2023 | 14,000.00 |
| Sep 30, 2023 | 7,000.00 |
| Sep 30, 2023 | 7,000.00 |
| Dec 31, 2022 | 35,000.00 |
| Dec 31, 2022 | 35,000.00 |
| Sep 30, 2022 | 84,000.00 |
| Sep 30, 2022 | 84,000.00 |
| Jun 30, 2022 | 33,000.00 |
| Jun 30, 2022 | 33,000.00 |
| Mar 31, 2022 | 9,000.00 |
| Mar 31, 2022 | 9,000.00 |